|
|
|
Volumn 145, Issue 17, 2003, Pages 47-49
|
|
Graves' disease, toxic and nodular goiter - Should your patient have radioiodine therapy as first line treatment?;Morbus basedow, schilddrüsenautonomie, knotenstruma - Wann ist die radioiodtherapie sinnvoll?
a
|
|
Author keywords
Autonomy; First line therapy; Graves' disease; Radioiodine therapy
|
|
Indexed keywords
ANTITHYROID AGENT;
RADIOACTIVE IODINE;
EYE DISEASE;
GRAVES DISEASE;
HOSPITALIZATION;
HUMAN;
HYPERTHYROIDISM;
NODULAR GOITER;
ORGAN SIZE;
PREGNANCY;
RELAPSE;
RISK FACTOR;
SHORT SURVEY;
THYROID GLAND;
TOXIC GOITER;
TREATMENT CONTRAINDICATION;
TREATMENT INDICATION;
TREATMENT OUTCOME;
ANTITHYROID AGENTS;
GOITER, NODULAR;
GRAVES DISEASE;
HUMANS;
HYPERTHYROIDISM;
IODINE RADIOISOTOPES;
PATIENT EDUCATION;
RADIONUCLIDE IMAGING;
THYROID GLAND;
|
|
EID: 0037621732
PISSN: 14383276
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (1)
|
|
References (0)
|
